Extracorporeal Membrane Oxygenation for Refractory Respiratory Failure

被引：0

作者：

Razo Vazquez A.O. ^{[1
]}

Ramsay J. ^{[1
]}

机构：

[1] Department of Anesthesia, University of California, San Francisco, 500 Parnassus Avenue, MU, San Francisco, 94143, CA

来源：

Current Anesthesiology Reports | 2015年 / 5卷 / 4期

关键词：

ARDS; ECMO; Lung transplantation; VA ECMO; VV ECMO;

D O I：

10.1007/s40140-015-0139-0

中图分类号：

学科分类号：

摘要：

Extracorporeal membrane oxygenation (ECMO) has been used now for more than four decades, and although initial clinical use and evidence were controversial of its benefit, technological advances in the components of the circuit, increase clinical experience, and further clinical evidence in the past decade have increased the number of centers that have employed this technology. ECMO employed as a rescue treatment for refractory respiratory failure has gained increasing support due to improvement in technology and emerging clinical evidence. The main indication for ECMO for respiratory failure is ARDS due to infection; however, recently there has been an increase in the use of ECMO for decompensated end-stage respiratory failure in patients awaiting lung transplantation. Possible contraindications for ECMO are inability to anticoagulate and the presence of malignancy. The current evidence has shown optimistic survival rates as well as quality of life that justify its use for refractory respiratory failure. © 2015, Springer Science + Business Media New York.

引用

页码：380 / 386

页数：6

共 13 条

[1]

Combes A., Bacchatta M., Brodie D., Et al., Extracorporeal membrane oxygenation for respiratory failure in adults, Curr Opin Crit Care, 18, pp. 99-104, (2012)

[2]

Peek G.J., Mugford M., Tiruvoipati R., Et al., Efficacy and economic assessmet of conventional ventilatory support versus extracorporeal membrane oxygenation for sever adult respiratory failure (CESAR): A multicentre randomized controlled trial, Lancet, 374, pp. 1351-1363, (2009)

[3]

Davies A., Jones D., Bailey M., Et al., Australia and New Zealand Extracorporeal Membrane Oxygenation(ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome, JAMA, 302, 17, pp. 1888-1895, (2009)

[4]

Murray J.F., Matthay M.A., Luce J.M., Et al., An expanded definition of the adult respiratory distress syndrome, Am Rev Respir Dis, 138, 3, pp. 720-723, (1988)

[5]

Rubenfeld G.D., Acute respiratory distress syndrome: the Berlin definition, JAMA, 307, 23, pp. 2526-2533, (2012)

[6]

Schmidt M., Bailey M., Sheldrake J., Et al., Predicting survival after extracorporeal membrane oxygenation in severe acute respiratory failure, the respiratory extracorporeal membrane oxygenation survival (RESP) score, AJRCCM, 189, pp. 1374-1382, (2014)

[7]

Veith F.J., Lung transplantation, Transplant Proc, 9, 1, pp. 203-208, (1977)

[8]

Hoopes C.W., Kukreja J., Golden J., Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation, J Thorac Cardiovasc Surg, 145, pp. 682-687, (2013)

[9]

Tayama E., Hayashida N., Akasu K., Et al., Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system, Artif Organs, 24, pp. 618-623, (2000)

[10]

Hemmila M.R., Rowe S.A., Boules T.N., Et al., Extracorporeal life support for severe acute respiratory distress syndrome in adults, Ann Thorac Surg, 240, pp. 595-605, (2004)

← 1 2 →